Christina Bluemel1, Ken Herrmann1, Francesco Giammarile2, Omgo E Nieweg3, Julien Dubreuil2, Alessandro Testori4, Riccardo A Audisio5, Odysseas Zoras6, Michael Lassmann1, Annette H Chakera3, Roger Uren7,8, Sotirios Chondrogiannis9, Patrick M Colletti10, Domenico Rubello11. 1. Department of Nuclear Medicine, Universitätsklinikum Würzburg, Würzburg, Germany. 2. Médecine Nucléaire, Hospices Civils de Lyon and EA 3738, Université Claude Bernard Lyon 1, Lyon, France. 3. Melanoma Institute Australia, The Poche Centre, North Sydney, Australia. 4. European Institute of Oncology, Milan, Italy. 5. St Helens Teaching Hospital, University of Liverpool, St Helens, UK. 6. Department of Surgical Oncology, University Hospital of Heraklion, Heraklion, Greece. 7. Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. 8. Alfred Nuclear Medicine and Ultrasound, RPAH Medical Centre, Newtown, NSW, Australia. 9. Department of Nuclear Medicine, PET/CT Centre, Radiology, NeuroRadiology, Medical Physics, 'Santa Maria della Misericordia' Hospital, Rovigo, Italy. 10. Department of Radiology, University of Southern California, Los Angeles, CA, USA. 11. Department of Nuclear Medicine, PET/CT Centre, Radiology, NeuroRadiology, Medical Physics, 'Santa Maria della Misericordia' Hospital, Rovigo, Italy. domenico.rubello@libero.it.
Abstract
PURPOSE: Sentinel lymph node biopsy is an essential staging tool in patients with clinically localized melanoma. The harvesting of a sentinel lymph node entails a sequence of procedures with participation of specialists in nuclear medicine, radiology, surgery and pathology. The aim of this document is to provide guidelines for nuclear medicine physicians performing lymphoscintigraphy for sentinel lymph node detection in patients with melanoma. METHODS: These practice guidelines were written and have been approved by the European Association of Nuclear Medicine (EANM) to promote high-quality lymphoscintigraphy. The final result has been discussed by distinguished experts from the EANM Oncology Committee, national nuclear medicine societies, the European Society of Surgical Oncology (ESSO) and the European Association for Research and Treatment of Cancer (EORTC) melanoma group. The document has been endorsed by the Society of Nuclear Medicine and Molecular Imaging (SNMMI). CONCLUSION: The present practice guidelines will help nuclear medicine practitioners play their essential role in providing high-quality lymphatic mapping for the care of melanoma patients.
PURPOSE: Sentinel lymph node biopsy is an essential staging tool in patients with clinically localized melanoma. The harvesting of a sentinel lymph node entails a sequence of procedures with participation of specialists in nuclear medicine, radiology, surgery and pathology. The aim of this document is to provide guidelines for nuclear medicine physicians performing lymphoscintigraphy for sentinel lymph node detection in patients with melanoma. METHODS: These practice guidelines were written and have been approved by the European Association of Nuclear Medicine (EANM) to promote high-quality lymphoscintigraphy. The final result has been discussed by distinguished experts from the EANM Oncology Committee, national nuclear medicine societies, the European Society of Surgical Oncology (ESSO) and the European Association for Research and Treatment of Cancer (EORTC) melanoma group. The document has been endorsed by the Society of Nuclear Medicine and Molecular Imaging (SNMMI). CONCLUSION: The present practice guidelines will help nuclear medicine practitioners play their essential role in providing high-quality lymphatic mapping for the care of melanomapatients.
Authors: Georgia M Beasley; Paul Speicher; Ketan Sharma; Hilliard Seigler; April Salama; Paul Mosca; Douglas S Tyler Journal: J Am Coll Surg Date: 2013-12-24 Impact factor: 6.113
Authors: J R van der Vorst; B E Schaafsma; F P R Verbeek; R J Swijnenburg; M Hutteman; G J Liefers; C J H van de Velde; J V Frangioni; A L Vahrmeijer Journal: Br J Dermatol Date: 2013-01 Impact factor: 9.302
Authors: Christina Bluemel; Gonca Safak; Andreas Cramer; Achim Wöckel; Anja Gesierich; Elena Hartmann; Jan-Stefan Schmid; Franz Kaiser; Andreas K Buck; Ken Herrmann Journal: Eur J Nucl Med Mol Imaging Date: 2016-06-17 Impact factor: 9.236
Authors: Claudiu Peştean; Elena Bărbuş; Andra Piciu; Maria Iulia Larg; Alexandrina Sabo; Cristina Moisescu-Goia; Doina Piciu Journal: Clujul Med Date: 2016-10-20
Authors: Maria Evertsson; Pontus Kjellman; Magnus Cinthio; Roger Andersson; Thuy A Tran; Rene In't Zandt; Gustav Grafström; Hanna Toftevall; Sarah Fredriksson; Christian Ingvar; Sven-Erik Strand; Tomas Jansson Journal: Sci Rep Date: 2017-07-06 Impact factor: 4.379